首页> 外文期刊>Behavioural Brain Research: An International Journal >Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice.
【24h】

Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice.

机译:在C57BL / 6J小鼠中,多巴胺D4受体激动剂PD168,077对抑制性避免学习反应的记忆巩固的促进作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The still unknown contribution of the D4 receptors to memory consolidation was studied examining the memory effects of the dopamine D4 agonist PD168,077, the putative dopamine D4 antagonist L745,870, their mutual combination, and the combination of the D4 agonist with representative compounds acting as agonist or antagonist on the D1, D2 and the D3 receptors. Memory consolidation was assessed in C57BL/6J mice using the one-trial step-through inhibitory avoidance task, the compounds being injected immediately after training (foot-shock) and performance measured 24h later. PD168,077 (0.5-10mg/kg) dose-dependently improved memory performance and L745,870 (0.05-5mg/kg) at doses lower than 1mg/kg increased and at doses higher than 1mg/kg impaired memory performance. PD168,077 did not affect the paradoxical promnesic effect of low doses (0.1-0.5mg/kg) of L745,870, but antagonised the memory-impairing effect induced by 5mg/kg L745,870. The D1 antagonist SCH23390 (0.025-0.05 mg/kg) and the D2 antagonist eticlopride (0.01-0.05 mg/kg) antagonised the promnesic effects of PD168,077, which attenuated the decreasing effect on memory consolidation of both D1 and D2 antagonists. Accordingly, the D1 agonist SKF38393 (5-20mg/kg) and the D2 agonist quinelorane (0.1-1 mg/kg) both synergistically magnified the memory-improving effects of the D4 agonist. The dopamine D3 antagonist U99194A (2.5-10mg/kg) did not affect the promnesic effects induced by the D4 agonist, which nevertheless abolished the U99194A-induced promnesic effects. Additionally, the amnesic effects produced by the D3 agonist 7-OH-DPAT (0.01-1 microg/kg) was attenuated by PD168,077. These results suggest a potential role of dopamine D4 receptors in memory consolidation, which would be similar to that of the D1 and D2 receptors and probably opposite to that of the D3 receptors.
机译:研究了D4受体对记忆巩固的未知的贡献,研究了多巴胺D4激动剂PD168,077,推定的多巴胺D4拮抗剂L745,870的记忆作用,它们的相互结合以及D4激动剂与具有代表性的化合物的结合作为D1,D2和D3受体的激动剂或拮抗剂。在C57BL / 6J小鼠中,使用单次试验性抑制性避免任务评估了记忆巩固,在训练后立即注射化合物(足部震动),并在24小时后测量性能。 PD168,077(0.5-10mg / kg)剂量依赖性地改善记忆力,而L745,870(0.05-5mg / kg)小于1mg / kg的剂量会增加,而大于1mg / kg的剂量会损害记忆力。 PD168,077并未影响低剂量(0.1-0.5mg / kg)的L745,870的反常记忆效应,但拮抗了5mg / kg L745,870引起的记忆障碍效应。 D1拮抗剂SCH23390(0.025-0.05 mg / kg)和D2拮抗剂依替普利(0.01-0.05 mg / kg)拮抗了PD168,077的促记忆作用,从而减弱了D1和D2拮抗剂对记忆巩固的降低作用。因此,D1激动剂SKF38393(5-20​​mg / kg)和D2激动剂喹诺烷(0.1-1mg / kg)都协同放大了D4激动剂的记忆改善作用。多巴胺D3拮抗剂U99194A(2.5-10mg / kg)不影响D4激动剂引起的预后作用,但该作用取消了U99194A引起的预后作用。此外,PD168,077减弱了D3激动剂7-OH-DPAT(0.01-1 microg / kg)产生的记忆删除效果。这些结果表明多巴胺D4受体在记忆巩固中的潜在作用,与D1和D2受体相似,并且可能与D3受体相反。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号